Investing Profile

Caroline Gaynor

InvestorVC
Princiipal at Lightstone Ventures
Photo of Caroline Gaynor, Principal at Lightstone Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
3
$250M
CompanyStageDateRound SizeTotal Raised
Amber Therapeutics
Series AJun 2024$100M
$100M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), Tiffany Le (New Enterprise Associates (NEA)), Kevin Chu (F-Prime Capital Partners)
ProVerum Medical
Series AJan 2022$34M
$34M
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Houman Ashrafian (SV Health Investors), Maina Bhaman (Soffinova Partners), Jack Kenney (SV Health Investors)